199 related articles for article (PubMed ID: 30035339)
21. Odor Identification Impairment and Change with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment.
Devanand DP; Liu X; Chunga RE; Cohen H; Andrews H; Schofield PW; Stern Y; Huey ED; Choi J; Pelton GH
J Alzheimers Dis; 2020; 75(3):845-854. PubMed ID: 32333591
[TBL] [Abstract][Full Text] [Related]
22. rCBF and cognitive impairment changes assessed by SPECT and ADAS-cog in late-onset Alzheimer's disease after 18 months of treatment with the cholinesterase inhibitors donepezil or galantamine.
Shirayama Y; Takahashi M; Oda Y; Yoshino K; Sato K; Okubo T; Iyo M
Brain Imaging Behav; 2019 Feb; 13(1):75-86. PubMed ID: 29247294
[TBL] [Abstract][Full Text] [Related]
23. Default Mode Network Functional Connectivity in Early and Late Mild Cognitive Impairment: Results From the Alzheimer's Disease Neuroimaging Initiative.
Lee ES; Yoo K; Lee YB; Chung J; Lim JE; Yoon B; Jeong Y;
Alzheimer Dis Assoc Disord; 2016; 30(4):289-296. PubMed ID: 26840545
[TBL] [Abstract][Full Text] [Related]
24. Brain controllability distinctiveness between depression and cognitive impairment.
Fang F; Gao Y; Schulz PE; Selvaraj S; Zhang Y
J Affect Disord; 2021 Nov; 294():847-856. PubMed ID: 34375212
[TBL] [Abstract][Full Text] [Related]
25. Identifying and characterizing different stages toward Alzheimer's disease using ordered core features and machine learning.
Sheng J; Wang B; Zhang Q; Zhou R; Wang L; Xin Y
Heliyon; 2021 Jun; 7(6):e07287. PubMed ID: 34189320
[TBL] [Abstract][Full Text] [Related]
26. A Deep Learning approach for Diagnosis of Mild Cognitive Impairment Based on MRI Images.
Gorji HT; Kaabouch N
Brain Sci; 2019 Aug; 9(9):. PubMed ID: 31466398
[TBL] [Abstract][Full Text] [Related]
27. Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL.
Dichgans M; Markus HS; Salloway S; Verkkoniemi A; Moline M; Wang Q; Posner H; Chabriat HS
Lancet Neurol; 2008 Apr; 7(4):310-8. PubMed ID: 18296124
[TBL] [Abstract][Full Text] [Related]
28. Cortical thickness predicts remission of depression with antidepressants in patients with late-life depression and cognitive impairment.
Motter JN; Lee S; Sneed JR; Doraiswamy PM; Pelton GH; Petrella JR; Devanand DP
J Affect Disord; 2021 Dec; 295():438-445. PubMed ID: 34507224
[TBL] [Abstract][Full Text] [Related]
29. Deep Learning and Risk Score Classification of Mild Cognitive Impairment and Alzheimer's Disease.
Nagaraj S; Duong TQ
J Alzheimers Dis; 2021; 80(3):1079-1090. PubMed ID: 33646166
[TBL] [Abstract][Full Text] [Related]
30. Donepezil for mild cognitive impairment.
Birks J; Flicker L
Cochrane Database Syst Rev; 2006 Jul; (3):CD006104. PubMed ID: 16856114
[TBL] [Abstract][Full Text] [Related]
31. Antidepressant, anxiolytic and procognitive effects of rivastigmine and donepezil in the chronic mild stress model in rats.
Papp M; Gruca P; Lason-Tyburkiewicz M; Willner P
Psychopharmacology (Berl); 2016 Apr; 233(7):1235-43. PubMed ID: 26769042
[TBL] [Abstract][Full Text] [Related]
32. Mild Cognitive Impairment Subtypes in Older People With Depressive Symptoms: Relationship With Clinical Variables and Hippocampal Change.
Jayaweera HK; Hickie IB; Duffy SL; Hermens DF; Mowszowski L; Diamond K; Terpening Z; Paradise M; Lewis SJ; Lagopoulos J; Naismith SL
J Geriatr Psychiatry Neurol; 2015 Sep; 28(3):174-83. PubMed ID: 25762610
[TBL] [Abstract][Full Text] [Related]
33. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
[TBL] [Abstract][Full Text] [Related]
34. White matter microstructural damage and depressive symptoms in patients with mild cognitive impairment and cerebral small vessel disease: the VMCI-Tuscany Study.
Pasi M; Poggesi A; Salvadori E; Diciotti S; Ciolli L; Del Bene A; Marini S; Nannucci S; Pescini F; Valenti R; Ginestroni A; Toschi N; Mascalchi M; Inzitari D; Pantoni L
Int J Geriatr Psychiatry; 2016 Jun; 31(6):611-8. PubMed ID: 26489377
[TBL] [Abstract][Full Text] [Related]
35. Cholinesterase inhibitor adjunctive therapy for cognitive impairment and depressive symptoms in older adults with depression.
McDermott CL; Gray SL
Ann Pharmacother; 2012 Apr; 46(4):599-605. PubMed ID: 22414791
[TBL] [Abstract][Full Text] [Related]
36. Donepezil for mild and moderate Alzheimer's disease.
Birks J S; Melzer D
Cochrane Database Syst Rev; 2000; (2):CD001190. PubMed ID: 10796620
[TBL] [Abstract][Full Text] [Related]
37. Donepezil for vascular cognitive impairment.
Malouf R; Birks J
Cochrane Database Syst Rev; 2004; (1):CD004395. PubMed ID: 14974068
[TBL] [Abstract][Full Text] [Related]
38. Endocytosis-pathway polygenic scores affects the hippocampal network connectivity and individualized identification across the high-risk of Alzheimer's disease.
Zhu Y; Zang F; Liu X; Fan D; Zhang Q; Ren Q; Xie C;
Brain Imaging Behav; 2021 Jun; 15(3):1155-1169. PubMed ID: 32803660
[TBL] [Abstract][Full Text] [Related]
39. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
Nogueira J; Freitas S; Duro D; Almeida J; Santana I
Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
